1. Home
  2. HIO vs BCYC Comparison

HIO vs BCYC Comparison

Compare HIO & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset High Income Opportunity Fund Inc.

HIO

Western Asset High Income Opportunity Fund Inc.

HOLD

Current Price

$3.59

Market Cap

349.0M

Sector

Finance

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$4.03

Market Cap

310.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HIO
BCYC
Founded
1993
2009
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
349.0M
310.7M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
HIO
BCYC
Price
$3.59
$4.03
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$13.90
AVG Volume (30 Days)
339.3K
292.3K
Earning Date
01-01-0001
04-30-2026
Dividend Yield
10.33%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.52
$3.99
52 Week High
$4.05
$9.18

Technical Indicators

Market Signals
Indicator
HIO
BCYC
Relative Strength Index (RSI) 44.19 32.14
Support Level $3.53 N/A
Resistance Level $3.70 $4.75
Average True Range (ATR) 0.03 0.18
MACD -0.00 -0.03
Stochastic Oscillator 29.17 5.96

Price Performance

Historical Comparison
HIO
BCYC

About HIO Western Asset High Income Opportunity Fund Inc.

Western Asset High Income Oppor Fd Inc is a diversified closed-end management investment company. The company's primary objective is to seek high current income and the secondary objective is capital appreciation. It invests a majority of its net assets in high-yield corporate debt securities and the rest in common stock equivalents, including options, warrants, and rights. The company invests in securities of companies from various sectors such as energy, technology, utilities, industrials, communications, finance, and capital goods among others.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.

Share on Social Networks: